With the analysis among 1,379 patents, we discovered top 165 key players by total patent application. Bristol Myers Squibb Co., Exelixis, Inc., Merck Sharp & Dohme Corp. are dominant in this area. They take 34.45% of the total patent filing.
New York, United States
Patent: 364
California, United States
Patent: 62
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 49
Indiana, United States
Patent: 35
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 35
Basel-Stadt, Switzerland
Patent: 33
Massachusetts, United States
Patent: 33
New Jersey, United States
Patent: 30
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 30
Rhizen Pharmaceuticals AG
Neuchâtel, Switzerland
Patent: 30
With the analysis among 23 patents, we discovered top 4 start-ups by total patent application. Asana BioSciences LLC, Seal Rock Therapeutics, Inc., Biosplice Therapeutics, Inc. are active in this area.
New Jersey, United States
Patent: 18
Seal Rock Therapeutics, Inc.
Washington, United States
Patent: 3
Biosplice Therapeutics, Inc.
California, United States
Patent: 1
New York, United States
Patent: 1
With the analysis among related 448 patents applied in the last 5 years. We discover 111 most active companies in this area. The fast-growing Verastem, Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Bristol Myers Squibb Co. take 20.54% of patent filing during this period.
Massachusetts, United States
Patent: 33
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 30
New York, United States
Patent: 29
New Jersey, United States
Patent: 25
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 21
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 18
Jiaxing Tekeluo Biotechnology Co. Ltd.
Sichuan Sheng, China
Patent: 18
Suzhou Yasheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 16
Institute Of Cancer Research
CGeneTech (Suzhou, China) Co. Ltd.
Jiangsu Sheng, China
Patent: 11
With the analysis among related 448 patents in last 5 years, we discover 88 new entrants. Verastem, Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Daiichi Sankyo Co., Ltd. are the most active new entrants in this area.
Massachusetts, United States
Patent: 33
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 30
New Jersey, United States
Patent: 25
Nanjing Mingde New Drug Research and Development Co., Ltd.
Jiangsu Sheng, China
Patent: 21
Jiaxing Tekeluo Biotechnology Co. Ltd.
Sichuan Sheng, China
Patent: 18
Suzhou Yasheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 16
Institute Of Cancer Research
CGeneTech (Suzhou, China) Co. Ltd.
Jiangsu Sheng, China
Patent: 11
Molecular Skin Therapeutics, Inc.
California, United States
Patent: 10
Hinova Pharmaceuticals, Inc.
Sichuan Sheng, China
Patent: 9
With the analysis among 193 patents, we discovered top 57 universities and scientific research institutions by total patent application. Institute Of Cancer Research, China Pharmaceutical University, Shanghai Institute of Pharmaceutical Industry are dominant in this area. They take 25.39% of the total patent filing.
Institute Of Cancer Research
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 8
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 8
Consejo Superior de Investigaciones Científicas
North Carolina, United States
Patent: 6
Texas, United States
Patent: 6
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 6
Sichuan Sheng, China
Patent: 6
Alma Mater Studiorum - Università di Bologna
Emilia-Romagna, Italy
Patent: 4
Pennsylvania, United States
Patent: 3